Overview

Study to Compare Ferric Carboxymaltose With Placebo in Patients With Acute Heart Failure and Iron Deficiency

Status:
Completed
Trial end date:
2020-07-21
Target enrollment:
Participant gender:
Summary
Study to Compare Ferric Carboxymaltose With Placebo in Patients With Acute Heart Failure and Iron Deficiency (Affirm-AHF)
Phase:
Phase 4
Details
Lead Sponsor:
Vifor (International) Inc.
Vifor Inc.
Collaborators:
Cytel Inc.
Worldwide Clinical Trials
Treatments:
Ferric Compounds